Alan J. Garber, MD, PhD, FACE, graduated from Temple University, Philadelphia, in 1968, completed a PhD in Biochemistry in 1971, and a residency in Internal Medicine. Subsequently, he was a fellow in Metabolism and then a junior faculty member at Washington University Medical School and Barnes Hospital in St. Louis. In 1974, he transferred to Baylor College of Medicine in Houston, where he is presently a Professor in the Departments of Medicine, Biochemistry and Molecular Biology, and Molecular and Cellular Biology.
Prior service to the boards of numerous organizations includes the National Board of Directors of The American Association of Clinical Endocrinologists, the American Diabetes Association, the Southern Section of the American Federation of Clinical Research and the Southern Society for Clinical Investigation. Prior elected positions include those of Secretary, American Association of Clinical Endocrinologists, and President of the Southern Society for Clinical Research, The Southern Society for Clinical Investigation, and the Texas Affiliate of the American Diabetes Association. He is currently Treasurer of the American Association of Clinical Endocrinologists. Consulting positions include the NIH, the National Heart, Lung and Blood Institute, the American Heart Association and the National Kidney Foundation. Editorial experience includes having served as the editor of Clinical Diabetes, Endocrine and Metabolism Clinics of North America and Medical Clinics of North America. Dr. Garber is presently the current Editor of Diabetes, Obesity and Metabolism and Endocrine Today. In addition, Dr. Garber chaired the Writing Committee for the AACE/ACE Consensus Statement on Outpatient Guidelines for Glycemic Control (2002) and was the co-chair, as well as the chairman, of the Writing Committee for the Consensus Development Conference on Inpatient Diabetes and Metabolic Control (2003). Dr. Garber co-chaired the AACE/ACE/ADA 2006 Inpatient Diabetes and Control: A Call to Action Consensus Conference and chaired the Writing Panel which produced the resulting Consensus Statement recommending strategies for improving patient care. He is currently chair of the ACE Task Force and Consensus Panel on Diabetes and Pre-Diabetic States and recently chaired the Writing Committee for the Consensus Statement on “The Diagnosis and Management of Pre-Diabetes in the Continuum of Hyperglycemia: When Do the Risks of Diabetes Begin?” Additionally, Dr. Garber is a member of the NIH-FDA Expert Panel on Cardiovascular Biomarkers and is past-chair of the Council on Complications for the American Diabetes Association. He has authored over 225 peer-reviewed publications, as well as book chapters and monographs on diabetes, its complications and related disorders. |